All lobbying filings

Moderna, Inc.

Moderna, Inc. filed a Q2 report for Moderna, Inc. on July 16, 2026.

Lobbying for Moderna, Inc. · Pharmaceuticals

As filed: MODERNA, INC. for MODERNA, INC.

All filings by Moderna, Inc. · Everything Moderna, Inc. has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 16, 2026

Expenses

$290,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Massachusetts

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Vaccine Policy, FDA Vaccine Approvals

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.